CLEARLINE CAPITAL LP CytomX Therapeutics, Inc. Transaction History

CLEARLINE CAPITAL LP portfolio value:

$285,000
portfolio value

CLEARLINE CAPITAL LP quarter portfolio value change:

-20.77%
quarter

CytomX Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -75K $1.45 196.58K
Q2 2022 share Increase +3.14% 5.98K shares -149K $1.83 196.58K
Q1 2022 share Increase +31.45% 45.6K shares -119K $2.67 190.6K
Q4 2021 share Increase 0.00% 145K shares 628K $4.4 145K